Physician profile
Mitchell V Brodey
NPI 1174501498
$10,754.83
in general payments reported to CMS, 2019-2025
51 companies · $2,220 in 2025
The $2,220 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.31 · 2020: $1,584 · 2021: $1,554 · 2022: $1,586 · 2023: $1,544 · 2024: $2,170 · 2025: $2,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,840 · Education: $93.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,839.70 |
| Education | $93.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,337.62 | 2020-2025 | Dovato, Rukobia |
| Glaxosmithkline, LLC. | $1,148.11 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $1,015.60 | 2021-2025 | Vraylar, Avycaz, Teflaro |
| Novo Nordisk INC | $969.51 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $822.80 | 2019-2025 | |
| Gilead Sciences, INC. | $797.85 | 2020-2025 | Descovy, Biktarvy |
| Astrazeneca Pharmaceuticals LP | $393.83 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Janssen Biotech, INC. | $372.71 | 2020-2023 | Symtuza |
| Lilly USA, LLC | $297.51 | 2020-2025 | Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $274.49 | 2020-2022 | |
| Astellas Pharma US INC | $258.23 | 2020-2025 | Cresemba, Veozah |
| Madrigal Pharmaceuticals | $210.22 | 2025 | Rezdiffra |
| Janssen Pharmaceuticals, INC | $193.98 | 2023-2024 | Xarelto |
| Amarin Pharma, INC. | $189.41 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $185.64 | 2021-2025 | Gardasil 9, Capvaxive, Zerbaxa |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $169.13 | 2020-2025 | Jardiance, Tradjenta, Synjardy |
| Insmed, INC. | $156.69 | 2021-2024 | Arikayce |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $155.13 | 2020-2025 | Xifaxan, Trulance |
| Shionogi INC | $153.65 | 2022-2025 | Fetroja |
| Takeda Pharmaceuticals U.S.A., INC. | $139.53 | 2021-2023 | Trintellix |
| Amgen INC. | $119.26 | 2023-2025 | Repatha, Otezla, Evenity |
| Exact Sciences Corporation | $104.97 | 2023-2025 | Cologuard Collection Kit |
| Ferring Pharmaceuticals INC. | $103.67 | 2022-2024 | Rebyota |
| Abbott Laboratories | $102.53 | 2022-2024 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $100.14 | 2023-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $94.98 | 2025 | Caplyta |
| Paratek Pharmaceuticals, INC. | $84.44 | 2020-2024 | Nuzyra |
| Theratechnologies INC. | $77.26 | 2020-2024 | Egrifta, Trogarzo |
| Allergan, INC. | $68.30 | 2020 | |
| Novartis Pharmaceuticals Corporation | $56.75 | 2024 | |
| Sanofi Pasteur INC. | $51.58 | 2025 | |
| Phadia US INC. | $46.36 | 2020-2022 | |
| Collegium Pharmaceutical, INC. | $45.27 | 2023-2024 | Belbuca, Xtampza |
| Otsuka America Pharmaceutical, INC. | $44.12 | 2024-2025 | Rexulti |
| Axsome Therapeutics, INC. | $42.71 | 2023-2024 | Auvelity |
| Shield Therapeutics INC | $42.45 | 2024-2025 | |
| Indivior INC. | $42.24 | 2024 | Sublocade |
| Intuitive Surgical, INC. | $33.62 | 2024 | |
| Alk-Abello, INC | $27.85 | 2024 | Odactra, Ragwitek, Grastek |
| Sumitomo Pharma America, INC. | $27.14 | 2025 | Gemtesa |
| Seqirus USA INC | $26.03 | 2025 | Fluad, Flucelvax |
| Insulet Corporation | $24.95 | 2025 | Omnipod |
| Csl Behring | $23.80 | 2023 | Hizentra |
| Cumberland Pharmaceuticals, INC. | $18.29 | 2024 | Kristalose |
| Daiichi Sankyo INC. | $18.14 | 2019 | |
| Grifols USA, LLC | $17.78 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $17.49 | 2023 | Austedo Xr |
| Genentech USA, INC. | $15.60 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $15.36 | 2022 | |
| Phathom Pharmaceuticals, INC. | $11.90 | 2025 | Voquezna |
| Inogen, INC. | $8.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Brodey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.